Nina is a founder of Avenna and Wellcode Life. Wellcode is a scientific wellness company which provides integrated health transformation programs tailored to individual’ unique molecular, genetic and physiological profile. Two years ago, Nina teamed up with Oxford scientists to form precision medicine company, Avenna. We work with scientists, medics and non-medical healthcare practitioners develop precision medicine pathways for early detection and treatment personalisation for chronic inflammatory diseases (“CIDs”). Current focus is on translation and commercialisation of promising glycomics technologies into practical clinical tools for inflammatory disease of bowels. Nina is a motivational speaker and travel the world to discover new solutions for CID prevention and healthy ageing.